Teva Pharmaceutical Industries Ltd (TEVA) has moved higher as of late, but there could definitely be trouble on the horizon for this company. That is because TEVA is now in overbought territory with an RSI value of 71.4. Furthermore, estimates for the Teva Pharmaceutical Industries Ltd have been coming down, pushing it to a Zacks Rank #4 (Sell). This suggests that investors may better off exiting this stock before it falls back to Earth.
TEVA PHARMACEUTICAL INDUSTRIES (TEVA): Free Stock Analysis Report
Zacks Investment Research
- Health Care Industry